Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 3
1(25.0%)
Phase 4
1(25.0%)
4Total
N/A(2)
Phase 3(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02966613Not ApplicableCompleted

Fully Disposable Patient-Specific Instrumentation

Role: lead

NCT02002624Not ApplicableCompleted

Patient-Specific Versus Conventional Instrumentation in TKA

Role: lead

NCT00208078Phase 4Terminated

Effect of Non-Invasive Ventilation in Cystic Fibrosis Patient With Chronic Respiratory Failure.

Role: lead

NCT00449228Phase 3Unknown

Efficacy of Preoperative Education and Mini-invasive Surgery for Total Hip Replacement

Role: collaborator

All 4 trials loaded